Ionis to hold second quarter 2026 financial results webcast

Webcast scheduled forWednesday, July 29at8:30 a.m. Eastern Time

CARLSBAD, Calif.--(BUSINESS WIRE)--Jul. 15, 2026--Ionis Pharmaceuticals, Inc.(Nasdaq: IONS) announced today that it will host a live webcast onWednesday, July 29at8:30 a.m. Eastern Timeto discuss its second quarter 2026 financial results and highlight progress on key programs.

The webcast may be accessed athttps://ir.ionis.com/events-and-presentations/upcoming-events. A replay will be available for a limited time at the same address.

For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has marketed medicines and a leading pipeline in neurology, cardiometabolic disease and select areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visitIonis.comand follow us onX(Twitter), LinkedInandInstagram.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260715218889/en/

Source: Ionis Pharmaceuticals, Inc.